$GNSS
Genasys Inc.

2024 Q4 Form 10-K Financial Statement

#000095017024136163 Filed on December 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024
Revenue $24.01M
YoY Change -48.55%
Cost Of Revenue $13.82M
YoY Change -44.5%
Gross Profit $10.19M
YoY Change -53.18%
Gross Profit Margin 42.44%
Selling, General & Admin $27.26M
YoY Change 10.72%
% of Gross Profit 267.55%
Research & Development $9.644M
YoY Change 18.67%
% of Gross Profit 94.65%
Depreciation & Amortization $2.929M
YoY Change 14.5%
% of Gross Profit 28.75%
Operating Expenses $36.91M
YoY Change 12.69%
Operating Profit -$26.72M
YoY Change 143.18%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$5.419M
YoY Change 54090.0%
Pretax Income -$32.14M
YoY Change 192.24%
Income Tax -$405.0K
% Of Pretax Income
Net Earnings -$31.73M
YoY Change 72.48%
Net Earnings / Revenue -132.16%
Basic Earnings Per Share -$0.72
Diluted Earnings Per Share -$0.72
COMMON SHARES
Basic Shares Outstanding 44.93M 44.60M 44.32M
Diluted Shares Outstanding 44.32M

Balance Sheet

Concept 2024 Q4 2024 Q3 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.945M
Short-Term Investments
Other Short-Term Assets $206.0K
YoY Change 3.52%
Inventory $7.313M
Prepaid Expenses
Receivables $3.283M
Other Receivables
Total Short-Term Assets $26.14M
YoY Change 3.7%
LONG-TERM ASSETS
Property, Plant & Equipment $1.291M
YoY Change -16.76%
Goodwill $13.33M
YoY Change 29.63%
Intangibles $8.506M
YoY Change 0.94%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $27.80M
YoY Change 12.55%
TOTAL ASSETS
Total Short-Term Assets $26.14M
Total Long-Term Assets $27.80M
Total Assets $53.94M
YoY Change 8.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.034M
YoY Change 44.85%
Accrued Expenses $9.030M
YoY Change 20.95%
Deferred Revenue $5.249M
YoY Change 51.31%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.09M
YoY Change 25.1%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $14.09M
Total Long-Term Liabilities
Total Liabilities $36.37M
YoY Change 126.02%
SHAREHOLDERS EQUITY
Retained Earnings -$107.8M
YoY Change 41.72%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.56M
YoY Change
Total Liabilities & Shareholders Equity $53.94M
YoY Change 8.08%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024
OPERATING ACTIVITIES
Net Income -$31.73M
YoY Change 72.48%
Depreciation, Depletion And Amortization $2.929M
YoY Change 14.5%
Cash From Operating Activities -$19.45M
YoY Change 102.79%
INVESTING ACTIVITIES
Capital Expenditures $191.0K
YoY Change -20.08%
Acquisitions $908.0K
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.666M
YoY Change -256.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $10.45M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.87M
YoY Change -21041.23%
NET CHANGE
Cash From Operating Activities -19.45M
Cash From Investing Activities -8.666M
Cash From Financing Activities 23.87M
Net Change In Cash -4.229M
YoY Change 2.15%
FREE CASH FLOW
Cash From Operating Activities -$19.45M
Capital Expenditures $191.0K
Free Cash Flow -$19.65M
YoY Change 99.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0000924383
CY2024 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024 us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
CY2024 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
0-24248
CY2024 dei Entity Registrant Name
EntityRegistrantName
GENASYS INC.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0361799
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
16262 West Bernardo Drive,
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92127
CY2024 dei City Area Code
CityAreaCode
858
CY2024 dei Local Phone Number
LocalPhoneNumber
676-1112
CY2024 dei Security12b Title
Security12bTitle
Common stock, $0.00001 par value per share
CY2024 dei Trading Symbol
TradingSymbol
GNSS
CY2024 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Public Float
EntityPublicFloat
88800000
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44928967
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024 dei Auditor Firm
AuditorFirmId
23
CY2024 dei Auditor Name
AuditorName
BAKER TILLY US, LLP
CY2024 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4945000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8665000
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7945000
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1481000
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
95000
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
758000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
65000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
65000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3283000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5952000
CY2024Q3 us-gaap Inventory Net
InventoryNet
7313000
CY2023Q3 us-gaap Inventory Net
InventoryNet
6501000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2559000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1851000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
26140000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
25208000
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
249000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
250000
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
96000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1291000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1551000
CY2024Q3 us-gaap Goodwill Gross
GoodwillGross
13329000
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
10282000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8506000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8427000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3110000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3886000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
1061000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
455000
CY2024Q3 us-gaap Assets
Assets
53936000
CY2023Q3 us-gaap Assets
Assets
49905000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4034000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2785000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9030000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7466000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1021000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1008000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14085000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11259000
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
12010000
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
6640000
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
369000
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
551000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3269000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4283000
CY2024Q3 us-gaap Liabilities
Liabilities
36373000
CY2023Q3 us-gaap Liabilities
Liabilities
16093000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44631030
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44631030
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36611240
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36611240
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
0
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
125690000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110379000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-107792000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-76062000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-335000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-505000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
17563000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
33812000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53936000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49905000
CY2024 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24008000
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46663000
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
13819000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
24901000
CY2024 us-gaap Gross Profit
GrossProfit
10189000
CY2023 us-gaap Gross Profit
GrossProfit
21762000
CY2024 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27261000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24621000
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9644000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8127000
CY2024 us-gaap Operating Expenses
OperatingExpenses
36905000
CY2023 us-gaap Operating Expenses
OperatingExpenses
32748000
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-26716000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-10986000
CY2024 us-gaap Investment Income Interest
InvestmentIncomeInterest
237000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
136000
CY2024 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
603000
CY2024 gnss Change In Fair Value Of Term Loan And Warrants
ChangeInFairValueOfTermLoanAndWarrants
-3950000
CY2024 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1103000
CY2023 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
146000
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5419000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32135000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10996000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-405000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7400000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-31730000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-18396000
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.5
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.5
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44316865
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44316865
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36939335
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36939335
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-31730000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-18396000
CY2024 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
18000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
80000
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
152000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
207000
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31560000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18109000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
50393000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1642000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
138000
CY2023 gnss Adjustments Related To Tax Withholding For Cashless Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForCashlessShareBasedCompensation
207000
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
45000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
287000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-18396000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
33812000
CY2024 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1652000
CY2024 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3265000
CY2024 gnss Stock Issued During Period Value Stock Options Exercised Cashless
StockIssuedDuringPeriodValueStockOptionsExercisedCashless
-43000
CY2024 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1051000
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10449000
CY2024 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
12000
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
170000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-31730000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
17563000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-31730000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-18396000
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2929000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2558000
CY2024 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
8000
CY2024 gnss Product Warranty Expense Benefit
ProductWarrantyExpenseBenefit
-56000
CY2023 gnss Product Warranty Expense Benefit
ProductWarrantyExpenseBenefit
31000
CY2024 us-gaap Inventory Write Down
InventoryWriteDown
4000
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
295000
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
1652000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1642000
CY2024 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3515000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2024 gnss Fair Value Adjustment Of Debt
FairValueAdjustmentOfDebt
435000
CY2023 gnss Fair Value Adjustment Of Debt
FairValueAdjustmentOfDebt
0
CY2024 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-525000
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
7373000
CY2024 gnss Gain Loss On Disposition Of Fixed Assets
GainLossOnDispositionOfFixedAssets
-6000
CY2023 gnss Gain Loss On Disposition Of Fixed Assets
GainLossOnDispositionOfFixedAssets
-4000
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
794000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
772000
CY2024 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-16000
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2024 us-gaap Accretion Expense
AccretionExpense
20000
CY2023 us-gaap Accretion Expense
AccretionExpense
49000
CY2024 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-110000
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2819000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-827000
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
816000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
788000
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1272000
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1671000
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2235000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
425000
CY2024 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
442000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-6064000
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19454000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9593000
CY2024 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
16206000
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3641000
CY2024 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
9403000
CY2023 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
9418000
CY2024 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
908000
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2024 gnss Payments To Acquire Asset Purchase Holdback Liability
PaymentsToAcquireAssetPurchaseHoldbackLiability
764000
CY2023 gnss Payments To Acquire Asset Purchase Holdback Liability
PaymentsToAcquireAssetPurchaseHoldbackLiability
0
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
191000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
239000
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8666000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5538000
CY2024 gnss Proceeds From Issuance Of Debt And Warrants
ProceedsFromIssuanceOfDebtAndWarrants
13698000
CY2023 gnss Proceeds From Issuance Of Debt And Warrants
ProceedsFromIssuanceOfDebtAndWarrants
0
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10449000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2024 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
138000
CY2024 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
219000
CY2023 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
CY2024 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
45000
CY2024 gnss Payment Tax Withholding Share Based Payment Arrangement Exercise Of Stock Options
PaymentTaxWithholdingShareBasedPaymentArrangementExerciseOfStockOptions
43000
CY2023 gnss Payment Tax Withholding Share Based Payment Arrangement Exercise Of Stock Options
PaymentTaxWithholdingShareBasedPaymentArrangementExerciseOfStockOptions
207000
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23873000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-114000
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29000
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4229000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4140000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9519000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13659000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5290000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9519000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4945000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8665000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
95000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
758000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
250000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
96000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5290000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9519000
CY2024 gnss Noncash Or Part Noncash Unrealized Loss On Marketable Securities
NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities
18000
CY2023 gnss Noncash Or Part Noncash Unrealized Loss On Marketable Securities
NoncashOrPartNoncashUnrealizedLossOnMarketableSecurities
71000
CY2024 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
21000
CY2024 gnss Initial Measurement Of Operating Lease Right Of Use Assets
InitialMeasurementOfOperatingLeaseRightOfUseAssets
0
CY2023 gnss Initial Measurement Of Operating Lease Right Of Use Assets
InitialMeasurementOfOperatingLeaseRightOfUseAssets
79000
CY2024 gnss Initial Measurement Of Operating Lease Liabilities
InitialMeasurementOfOperatingLeaseLiabilities
0
CY2023 gnss Initial Measurement Of Operating Lease Liabilities
InitialMeasurementOfOperatingLeaseLiabilities
79000
CY2024 gnss Shares Surrendered From Stock Option Exercises
SharesSurrenderedFromStockOptionExercises
0
CY2023 gnss Shares Surrendered From Stock Option Exercises
SharesSurrenderedFromStockOptionExercises
300000
CY2024 us-gaap Interest Paid Net
InterestPaidNet
603000
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
52000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2024 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. OPERATIONS</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Genasys Inc. is a global provider of Protective Communications solutions including its Genasys Protect software platform and Genasys Long Range Acoustical Devices (“LRAD”). The Company</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">’</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">s unified platform receives information from a wide variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. The Company uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations.</span></p>
CY2024Q3 gnss Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
8
CY2024Q3 gnss Number Of Additional Inactive Subsidiaries
NumberOfAdditionalInactiveSubsidiaries
1
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">USE OF ESTIMATES</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions (e.g., share-based compensation valuation, allowance for doubtful accounts for expected credit losses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, fair value of term loan and warrant liabilities, contingent consideration, valuation of inventory, goodwill and intangible assets, warranty reserve, valuation of operating lease right of use assets and operating lease liabilities, accrued bonus and valuation allowance related to deferred tax assets) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting periods. Actual results could materially differ from those estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CONCENTRATION OF CREDIT RISK</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company sells its products to a large number of geographically diverse customers. The Company routinely assesses the financial strength of its customers. It is customary for the Company to require a deposit as collateral. As of September 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, accounts receivable from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of total accounts receivable with no other single customer accounting for more than 10% of the accounts receivable balance. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, accounts receivable from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customers accounted for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">22</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of total accounts receivable with no other single customer accounting for more than 10% of the accounts receivable balance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company maintains cash and cash equivalent bank deposit accounts which, at times, may exceed federally insured limits guaranteed by the Federal Deposit Insurance Corporation (“FDIC”). As of September 30, 2024, there are $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">627</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of cash and cash equivalents retained in foreign banks.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has not experienced any losses in such accounts. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions. The Company also invests cash in instruments that meet high credit quality standards, as specified in the Company’s policy guidelines such as money market funds, corporate bonds, municipal bonds and Certificates of Deposit. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument. It is generally the Company’s policy to invest in instruments that have a final maturity of no longer than </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, with a portfolio weighted average maturity of no longer than </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> months.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2024Q3 gnss Cash And Cash Equivalents Retained In Foreign Banks
CashAndCashEquivalentsRetainedInForeignBanks
627000
CY2024 gnss Investments Typical Final Maturity
InvestmentsTypicalFinalMaturity
P3Y
CY2024 gnss Investments Typical Portfolio Weighted Average Maturity
InvestmentsTypicalPortfolioWeightedAverageMaturity
P18M
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4945000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8665000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
345000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
854000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
65000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
65000
CY2024 gnss Inventory Obsolescence Write Down Recoveries
InventoryObsolescenceWriteDownRecoveries
-284000
CY2023 gnss Inventory Obsolescence Write Down Recoveries
InventoryObsolescenceWriteDownRecoveries
288000
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024 gnss Shipping And Handling Costs
ShippingAndHandlingCosts
128000
CY2023 gnss Shipping And Handling Costs
ShippingAndHandlingCosts
289000
CY2024 us-gaap Advertising Expense
AdvertisingExpense
454000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
512000
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
76000
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
132000
CY2024 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
152000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
207000
CY2024 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RECLASSIFICATIONS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Where necessary, the prior year’s information has been reclassified to conform to the fiscal year 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> statement presentation. These reclassifications had no effect on previously reported results of operations or accumulated deficit.</span></p>
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
150000
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4020000
CY2024 gnss Contract With Customer Liability Increase For New Contract
ContractWithCustomerLiabilityIncreaseForNewContract
14457000
CY2024 gnss Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
12865000
CY2024 gnss Contract With Customer Liability Effect Of Exchange Rate
ContractWithCustomerLiabilityEffectOfExchangeRate
-6000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5618000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
369000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5249000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5618000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5249000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.93
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2024Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
684000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
496000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
8000
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1180000
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
10000
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5442000
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5086000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1377000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1029000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1331000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1218000
CY2024Q3 us-gaap Inventory Gross
InventoryGross
8150000
CY2023Q3 us-gaap Inventory Gross
InventoryGross
7333000
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
837000
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
832000
CY2024Q3 us-gaap Inventory Net
InventoryNet
7313000
CY2023Q3 us-gaap Inventory Net
InventoryNet
6501000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5519000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5325000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4228000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3774000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1291000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1551000
CY2024 us-gaap Depreciation
Depreciation
451000
CY2023 us-gaap Depreciation
Depreciation
450000
CY2024Q3 us-gaap Goodwill Gross
GoodwillGross
13329000
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
10282000
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Goodwill
Goodwill
10282000
CY2024 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2923000
CY2024 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
124000
CY2024Q3 us-gaap Goodwill
Goodwill
13329000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8427000
CY2024 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
2550000
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2478000
CY2024 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
7000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8506000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
17022000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14397000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8516000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5970000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8506000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8427000
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2478000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2108000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2358000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2222000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2048000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1220000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
329000
CY2024Q3 gnss Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
329000
CY2024Q3 gnss Finite Lived Intangible Assets Amortization Expense Total
FiniteLivedIntangibleAssetsAmortizationExpenseTotal
8506000
CY2024Q3 gnss Prepaid Professional Services
PrepaidProfessionalServices
595000
CY2023Q3 gnss Prepaid Professional Services
PrepaidProfessionalServices
136000
CY2024Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
540000
CY2023Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
417000
CY2024Q3 gnss Due And Subscription
DueAndSubscription
516000
CY2023Q3 gnss Due And Subscription
DueAndSubscription
261000
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
288000
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
264000
CY2024Q3 gnss Prepaid Trade Shows And Travel
PrepaidTradeShowsAndTravel
116000
CY2023Q3 gnss Prepaid Trade Shows And Travel
PrepaidTradeShowsAndTravel
150000
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
69000
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
123000
CY2024Q3 gnss Deposits For Inventory
DepositsForInventory
4000
CY2023Q3 gnss Deposits For Inventory
DepositsForInventory
301000
CY2024Q3 gnss Value Added Tax And Bank Withholdings
ValueAddedTaxAndBankWithholdings
225000
CY2023Q3 gnss Value Added Tax And Bank Withholdings
ValueAddedTaxAndBankWithholdings
133000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
206000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
66000
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2559000
CY2023Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1851000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3249000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2237000
CY2024Q3 gnss Short Term Provision
ShortTermProvision
155000
CY2023Q3 gnss Short Term Provision
ShortTermProvision
0
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
76000
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
132000
CY2024Q3 gnss Accrued Contract Costs
AccruedContractCosts
0
CY2023Q3 gnss Accrued Contract Costs
AccruedContractCosts
825000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
51000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
67000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9030000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7466000
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
132000
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
159000
CY2024 gnss Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties
ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties
-35000
CY2023 gnss Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties
ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties
40000
CY2024 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
21000
CY2023 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
67000
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
76000
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
132000
CY2024Q2 gnss Proceeds From Issuance Of Debt And Warrants Gross
ProceedsFromIssuanceOfDebtAndWarrantsGross
14700000
CY2024 gnss Increase In Lease Liability With10 Increase In Index
IncreaseInLeaseLiabilityWith10IncreaseInIndex
42000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3886000
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
794000
CY2024 gnss Effect Of Exchange Rate On Operating Lease Rou Assets
EffectOfExchangeRateOnOperatingLeaseROUAssets
18000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3110000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5291000
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
1020000
CY2024 gnss Effect Of Exchange Rate On Operating Lease Liability
EffectOfExchangeRateOnOperatingLeaseLiability
19000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4290000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3269000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1021000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1177000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1201000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1222000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1047000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4647000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
357000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4290000
CY2024 us-gaap Operating Lease Expense
OperatingLeaseExpense
982000
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
1003000
CY2024 us-gaap Short Term Lease Cost
ShortTermLeaseCost
25000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
19000
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
11000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
16000
CY2024 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
109000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
11000
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
120000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
27000
CY2024 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-390000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
6266000
CY2024 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-135000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1107000
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-525000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7373000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-405000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7400000
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6744000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2309000
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3466000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10376000
CY2024 gnss Nondeductible Compensation Interest Expense And Other
NondeductibleCompensationInterestExpenseAndOther
956000
CY2023 gnss Nondeductible Compensation Interest Expense And Other
NondeductibleCompensationInterestExpenseAndOther
232000
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-334000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-605000
CY2024 gnss Income Tax Reconciliation Change In Research And Development Carryover
IncomeTaxReconciliationChangeInResearchAndDevelopmentCarryover
-379000
CY2023 gnss Income Tax Reconciliation Change In Research And Development Carryover
IncomeTaxReconciliationChangeInResearchAndDevelopmentCarryover
-433000
CY2024 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
3051000
CY2023 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
111000
CY2024 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
104000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
28000
CY2024 gnss Income Tax Reconciliation Tax Impact Of Acquisition Accounting
IncomeTaxReconciliationTaxImpactOfAcquisitionAccounting
-525000
CY2023 gnss Income Tax Reconciliation Tax Impact Of Acquisition Accounting
IncomeTaxReconciliationTaxImpactOfAcquisitionAccounting
0
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-405000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7400000
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12357000
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10665000
CY2024Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4639000
CY2023Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4929000
CY2024Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
562000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
650000
CY2024Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1770000
CY2023Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2203000
CY2024Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
2227000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
2071000
CY2024Q3 gnss Capitalized Research And Experimental
CapitalizedResearchAndExperimental
3893000
CY2023Q3 gnss Capitalized Research And Experimental
CapitalizedResearchAndExperimental
1916000
CY2024Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
199000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
237000
CY2024Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25647000
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22671000
CY2024Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
216000
CY2023Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
274000
CY2024Q3 gnss Deferred Tax Liabilities Operating Rightofuse Assets
DeferredTaxLiabilitiesOperatingRightofuseAssets
619000
CY2023Q3 gnss Deferred Tax Liabilities Operating Rightofuse Assets
DeferredTaxLiabilitiesOperatingRightofuseAssets
907000
CY2024Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1592000
CY2023Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1736000
CY2024Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2427000
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2917000
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23220000
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19754000
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2024 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
455000
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
398000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5936639
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2904522
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.19
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1402250
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.04
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
511032
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.86
CY2024 gnss Share Based Compensation Arrangement By Share Based Payment Award Options Gross Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrossExercisesInPeriod
-100000
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.76
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3695740
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.84
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1192593
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.58
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3085000
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
365000
CY2024Q3 us-gaap Share Price
SharePrice
3.56
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000
CY2024 gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2980000
CY2023 gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
138000
CY2024 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
124000
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
815000
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3695740
CY2024 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y10M17D
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.84
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1192593
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.58
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1946000
CY2024 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.58
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.524
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.04
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y2M12D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P7Y
CY2024 us-gaap Dividends
Dividends
0
CY2023 us-gaap Dividends
Dividends
0
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1652000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1642000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
84765
CY2023 gnss Gross Proceeds From Stock Options Exercised
GrossProceedsFromStockOptionsExercised
138000
CY2023Q4 gnss Underwritten Public Offering Common Stock
UnderwrittenPublicOfferingCommonStock
5750000
CY2023Q4 gnss Price Per Share Underwritten Agreement
PricePerShareUnderwrittenAgreement
2
CY2023Q4 gnss Gross Proceeds From Underwritten Public Offering Common Stock
GrossProceedsFromUnderwrittenPublicOfferingCommonStock
11500000
CY2023Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1051000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-31730000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-18396000
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.5
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.5
CY2024 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
44316865
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
36939335
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44316865
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36939335
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7322252
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3359515
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-26716000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-10986000
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2929000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2558000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-405000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7400000
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
9797000
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
9978000
CY2024Q3 us-gaap Assets
Assets
53936000
CY2023Q3 us-gaap Assets
Assets
49905000
CY2024 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24008000
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46663000
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
9797000
CY2023Q3 us-gaap Noncurrent Assets
NoncurrentAssets
9978000

Files In Submission

Name View Source Status
0000950170-24-136163-index-headers.html Edgar Link pending
0000950170-24-136163-index.html Edgar Link pending
0000950170-24-136163.txt Edgar Link pending
0000950170-24-136163-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gnss-20240930.htm Edgar Link pending
gnss-20240930.xsd Edgar Link pending
gnss-ex21_1.htm Edgar Link pending
gnss-ex23_1.htm Edgar Link pending
gnss-ex31_1.htm Edgar Link pending
gnss-ex31_2.htm Edgar Link pending
gnss-ex32_1.htm Edgar Link pending
img37351596_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gnss-20240930_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending